NOVARTIS PRESENTA EN ESPAÑA GLIVEC, SU NUEVO MEDICAMENTO PARA EL TRATAMIENTO DE LA LEUCEMIA MIELOIDE CRONICA (LMC)The aim of our studies is to propose a statistical model of turboshaft engines ageing behaviour in order to improve the reliability level a...